ERBB2 on chromosome 17 was amplified in 5 cancer types and was co-amplified with the MAP kinase adaptor GRB7 and PPP1R1B. EGFR on chromosome 7 was amplified as a single gene in 7 cancer types, validating the importance of this drug target in cancer [16]. The gene discussed is ERBB2; the disease is cancer.